Class 2 Device Recall ACE EZA1c Reagent, Glycosylated hemoglobin assay.

• Date Initiated by Firm: August 22, 2008
• Date Posted: December 17, 2008
• Recall Status: Terminated on April 15, 2009
• Recall Number: Z-0482-2009
• Recall Event ID: 49563
• 510(K)Number: K070734
• Product Classification: Glycosylated Hemoglobin Assay - Product Code LCP
• Product: ACE and ACE Alera Hemoglobin A1C : EZA1C Reagent, EZA1C Controls, and EZA1C Calibrators. Hemoglobin A1c (EZA1c) Calibrators for Calibration of the Enzymatic Hemoglobin A1c (HbA1c) Assay. For in vitro diagnostic use only. Alfa Wassermann Diagnostic Technologies, LLC., 4 Henderson Drive, West Caldwell, NJ 07006. ACE EZA1c Reagent is intended for the quantitative determination of stable hemoglobin A1c in human whole blood samples using the ACE and Ace Alera clinical chemistry systems. Measurement of hemoglobin A1c is a viable indicator for long-term diabetic control.
• Code Information: EZA1c Reagent ACI-30, Lot # F2481, Exp. 9/2008 and EZA1c Reagent ACI-30, Lot # F2603, Exp 01/2009. The following EZA1c control and calibrator kits were included in the customer notification instructing them to discard the product. There is no use for these products without the reagent. (EZA1c Controls C2-82, Lot # HBC00507-1, Exp. 10/2008 and EZA1c Calibrators S2-82, Lot # HBS00907-1, Exp. 10/2008).
• FEI Number: 1000122044
• Recalling Firm/ Manufacturer: Alfa Wassermann, Inc.; 4 Henderson Dr; Caldwell NJ 07006-6608
• For Additional Information Contact: Dennis Taschek; 973-852-0177
• Manufacturer Reason for Recall: Internal studies observed occasional unexpected outlier results in whole blood samples tested for Hemoglobin A1c using the EZA1c reagent on the ACE or ACE Alera clinical chemistry systems.
• FDA Determined Cause: Component design/selection
• Action: An initial URGENT: CUSTOMER ADVISORY NOTICE dated August 22, 2008 was sent to all customers and distributors. The letter stated the problem and asked customers to cease using the EZA1C reagent, controls and calibrators. Customers were asked to hold any affected inventory while additional testing was conducted by Alfa Wassermann Diagnostic Technologies, LLC. (AWDT). A second communication, URGENT: CUSTOMER ADVISORY NOTICE (and Product Response Form) dated September 18, 2008 was sent instructing customers to destroy all product and package inserts in stock for the EZA1C products listed in the letter. Information was provided on receiving credit and an alternative product for use. Customers are requested to complete and return the Product Response Form by fax (888-646-2535) to AWDT indicating their receipt of the letter and the amount of product destroyed. Distributors' letters requested their customers be notified of the recall and that the Product Response Form be sent directly to AWDT. Direct questions to AWDT Customer Solution Center at 866-419-2532.
• Quantity in Commerce: Reagent Lot F2481 = 264 kits and Reagent Lot F2603 = 69 kits. (Control Lot HBC00507-1=322 kits and Calibrator Lot HBS00907-1=262 kits).
• Distribution: Nationwide Distribution.
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.

• 510(K) Database: 510(K)s with Product Code = LCP